Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading update

24 Nov 2014 07:00

RNS Number : 7387X
Elektron Technology PLC
24 November 2014
 



24 November 2014

 

Elektron Technology plc

 

Third quarter trading update

 

Elektron Technology plc (AIM: EKT, "Elektron" or the "Group"), the global technology group, provides an update on recent trading.

 

The Group is continuing to perform in line with the Board's expectations. Group sales for the third quarter from continuing operations amounted to £11.5m (2013: £11.8m) taking year to date sales to £33.6m (2013: £34.4m) with sales demand tracking the trend of the first half of the year. As expected the Group has seen some weakening in demand from its EMEA Connectivity distributor base due to difficult economic conditions and high stock levels. Conversely Instrumentation Monitoring and Control ("IMC") demand strengthened during the third quarter. The overdue sales backlog at 31 October had been lowered to £0.7 million (31 July 2014: £1.0 million; 31 January 2014: £2.1 million). There were no operating or financing related exceptional charges in the third quarter.

 

Net debt at 31 October was £2.7 million (31 July 2014: £4.7 million; 31 January 2014: £8.0 million).

 

The Group has begun to accelerate investment in key new product development programmes, in particular relating to its Checkit brand, with a number of strategic technical appointments complemented by outsourced development. Consequently the Group expects debt to rise in the final quarter but still be substantially below the half year position.

 

The Group continues to focus on maximising the performance of its existing portfolio of brands in the short term whilst developing and launching innovative new products to enable growth in the medium and longer term.

 

As announced at the half year results in September, the Board remains of the view that the Group's trading performance in the second half of the year will be similar to the first half.

 

John Wilson, Chief Executive Officer of Elektron said:

 

"The Group's delivery of a satisfactory performance in the third quarter is confirmation that our strategy remains on track. The Group is cash generative and we are placing considerable focus on using the funds raised earlier in the year to invest and execute our longer term strategy of building a high growth portfolio of brands through the introduction of best-in-class innovative products to the market." 

 

Enquiries:

 

Elektron Technology www.elektron-technology.com

+44 (0) 1223 371 000

John Wilson - Chief Executive Officer

Andy Weatherstone - Chief Financial Officer

finnCap (Nominated Adviser, Financial Adviser and Broker)

+44 (0)20 7220 0500

Ed Frisby/Scott Mathieson (Corporate Finance)

Malar Velaigam (Corporate Broking)

Instinctif Partners

+44 (0)20 7457 2020

Adrian Duffield/Kay Larsen

 

 

Notes to Editors 

Elektron conceives designs and markets innovative engineered products and services for businesses at its technology hub in Cambridge. It has a multi skilled team of engineers and product line specialists focused on the opportunities created by disruptive global trends in the following areas: 

 

· Demand for ubiquitous power and data: Connectivity Solutions

· Growth in high precision manufacture: Nano-positioning

· Healthcare for the ageing population: Ophthalmology

· Connected customer experiences and service delivery: E-Commerce and E-Service

 

In addition it owns a portfolio of well-established products and brands which provide customer access and feedback. 

 

Elektron Technology is headquartered in Cambridge and its shares are admitted to trading on the AIM market of the London Stock Exchange. 

 

Forward looking statements 

Statements contained in this statement are based on the knowledge and information available to the Company's directors at the date it was prepared and therefore the facts stated and views expressed may change after that date. By their nature, the statements concerning the risks and uncertainties facing the Company in this Statement involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. To the extent that this Statement contains any statement dealing with any time after the date of its preparation such statement is merely predictive and speculative as it relates to events and circumstances which are yet to occur. The Company undertakes no obligation to update these forward looking statements.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFELFMFFLSEDF
Date   Source Headline
29th Mar 20187:00 amRNSBulgin announces agreement with Arrow Electronics
6th Mar 20187:00 amRNSFSA successfully completes trials with Checkit
27th Feb 20187:00 amRNSHolding(s) in Company
16th Feb 20187:00 amRNSDisposal of Queensgate Nano
8th Feb 20187:00 amRNSTrading Statement
26th Jan 20183:37 pmRNSHolding(s) in Company
25th Jan 20185:58 pmRNSHolding(s) in Company
25th Jan 20187:00 amRNSAcquisition of IP in EET business
19th Jan 20183:45 pmRNSHolding(s) in Company
2nd Jan 20187:00 amRNSChange of Nominated Adviser and Broker
12th Dec 20177:00 amRNSGrant of Options
6th Dec 20174:02 pmRNSHolding(s) in Company
2nd Nov 20177:00 amRNSTrading Statement
23rd Oct 20174:16 pmRNSDirector/PDMR Shareholding
20th Oct 20177:00 amRNSDisposal of Sheen Instruments
16th Oct 201712:25 pmRNSHolding(s) in Company
27th Sep 20174:20 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSHalf-year Report
19th Sep 20177:00 amRNSContract Win
10th Aug 20177:00 amRNSTrading Update and Notification of Interim Results
31st Jul 20177:00 amRNSDisposal
13th Jul 201710:01 amRNSHolding(s) in Company
6th Jul 20173:00 pmRNSResult of AGM
6th Jul 20177:00 amRNSAGM Statement
16th Jun 201710:40 amRNSHolding(s) in Company
13th Jun 20177:57 amRNSHolding(s) in Company
6th Jun 201711:26 amRNSAnnual Report and Notice of AGM
18th May 20177:00 amRNSFinal Results
2nd May 20177:00 amRNSNotice of Results & AGM
27th Mar 20177:00 amRNSDisposal
8th Feb 20177:00 amRNSTrading Update
19th Jan 20177:00 amRNSDirector/PDMR Shareholding
14th Dec 20164:54 pmRNSHolding(s) in Company
13th Dec 20167:00 amRNSDirector/PDMR Shareholding
8th Dec 20169:00 amRNSReview of Operations
2nd Dec 20167:00 amRNSDisposal
30th Sep 20162:43 pmRNSDisposal of Carnation Designs
22nd Sep 20167:00 amRNSHalf-year Report
30th Aug 20169:52 amRNSHolding(s) in Company
1st Aug 20167:00 amRNSDirector/PDMR Shareholding
28th Jul 20163:56 pmRNSResult of AGM
28th Jul 20167:00 amRNSTrading Update
4th Jul 201610:40 amRNSLapsing of Options
30th Jun 20167:00 amRNSAnnual Report and Notice of AGM
9th Jun 20167:00 amRNSFinal Results
23rd May 20167:00 amRNSDisposal of Agar Scientific
18th May 20169:56 amRNSHolding(s) in Company
13th May 201610:06 amRNSHolding(s) in Company
20th Apr 20162:54 pmRNSDerivative Claim - Update
22nd Feb 20167:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.